Tamtam Try Tamtam free
Encompass Health logo

Encompass Health account plan

Rehabilitation hospital operations

At a glance

Encompass Health is the largest US operator of inpatient rehabilitation hospitals, with 177 hospitals and FY2025 revenue of $5,935.2 million.

Encompass Health (NYSE: EHC), based in Birmingham, Alabama, owns and operates inpatient rehabilitation hospitals for patients recovering from strokes, hip fractures, neurological conditions and other major injuries or illnesses. It had 177 hospitals in 39 states and Puerto Rico at September 30, 2026, concentrated in Florida and Texas, and 92% of its patients come from acute-care hospitals. FY2025 net operating revenues were $5,935.2 million (+10.5%), net income attributable to Encompass Health $566.2 million and Adjusted EBITDA $1,267.9 million. It employs over 42,000 people (24,611 full-time), and Medicare and Medicare Advantage provided 65.4% and 16.4% of 2025 revenue. It reports a single segment, inpatient rehabilitation, and more than a third of its hospitals are joint ventures with acute-care systems.

Business units

Strategic priorities

Adding hospital capacity
The pipeline beyond 2026 holds 15 hospitals with 654 beds, plus 150 to 200 bed additions in 2027; 517 beds were added in 2025 and six hospitals opened in 2026 through October.
Small-format hub-and-spoke hospitals
A 24-bed small-format prototype opens from late 2027 in Conroe and Richmond, Texas; about 200 potential locations have been identified, targeting an IRR of about 20% at about $1 million per bed.
North Carolina expansion
After the state repealed its certificate-of-need law effective October 1, 2026, the company prioritized 15 markets and put six real estate parcels under contract.
Medicare Advantage access
An admit-and-appeal pilot overturned 87% of 294 denied claims and is being extended to every hospital and payer; VA community care volume grew 21% in Q3 2026.
Workforce stability
Premium labor has fallen for 16 consecutive quarters to $23.1 million, contract labor is 0.9% of FTEs, and clinical ladders are used to retain nurses and therapists.

Latest results

In Q3 2026 net operating revenues rose 8.9% to $1,609.5 million on 5.7% discharge growth and a 4.0% rise in net patient revenue per discharge; adjusted EBITDA grew 15.5% to $346.6 million and net income attributable to Encompass Health 18.5% to $149.9 million. Nine-month revenues were $4,793.5 million (+9.2%). Bad debt reserves rose to 2.7% of revenue from 1.9% after a billing system conversion and are expected back to 2% to 2.5% in Q4. Guidance for 2026 was raised to revenue of $6.45 billion to $6.50 billion and adjusted EBITDA of $1.395 billion to $1.415 billion.

Investments and deals

2026 capital expenditure
Capex is expected at about $920 million to $995 million in 2026 (about $736 million in 2025), with about $535 million needed to finish projects under construction.
Oracle Fusion ERP and billing
The ERP moved to Oracle Fusion in October 2025 and patient billing moved from the legacy Patcom system to the Oracle module in Q2 2026.
Palantir partnership
The Palantir relationship was extended and expanded after 2025 work on admission documentation and claims denials; next projects cover CRM market analysis, revenue cycle management and clinical staffing.
Refinancing and buybacks
A new credit agreement in March 2026, $500 million of 5.875% Senior Notes due 2034 plus a $100 million add-on, and a buyback authorization raised to $1.0 billion, with 1.9 million shares repurchased for $203.7 million in nine months.

Challenges and risks

Review choice demonstration
From January 1, 2027, 108 of the company's hospitals (about 63% of its IRF Medicare claims) will be under prepayment review; the CFO's "greatest concern is whether or not Palmetto is going to be able to handle this administratively".
Medicare Advantage denials
MA conversion rates run 25% to 30% against the mid-60% for fee-for-service Medicare, and one national payer's conversion dropped about 500 basis points in Q4 2025.
Billing disruption
The Q2 2026 billing system conversion pushed bad debt to 2.7% of revenue, with legacy claims needing manual processing.
Reimbursement dependence
Most revenue comes from Medicare; the 2027 Final IRF Rule raises rates about 2.3%, and the TEAM bundled-payment model is cutting lower extremity joint replacement volumes.
Staffing
Shortages of nurses and therapists can force costlier contract labor; nurse turnover ticked up to 20.7% in Q3 2026.

What leadership says

“Our company has never before been presented with greater opportunity, and we have never been better positioned to capitalize.”

Mark J. Tarr, President and Chief Executive Officer · Q4 2025 earnings call, February 6, 2026

“we would all be collectively disappointed if we're opening less than six of those a year”

Mark J. Tarr, President and Chief Executive Officer · On small-format hospitals, Q3 2026 earnings call, October 29, 2026

“RCD is just a new acronym for the same old thing.”

Douglas E. Coltharp, Executive Vice President and Chief Financial Officer · Q4 2025 earnings call, February 6, 2026

Where a supplier can help

Hospital construction and fit-out
Tied to the capacity and small-format priorities and the 2026 capex budget: prefabricated construction, equipment and furnishing suppliers fit a pipeline of de novos, bed additions and small-format hospitals.
Revenue cycle and denial management
Tied to the billing disruption, RCD and Medicare Advantage challenges: claims processing, documentation and appeals tools address the bad debt rise and prepayment review.
Clinical documentation AI
Tied to the Palantir partnership and documentation burden: AI tools that reduce clinician documentation time and support medical necessity records fit the stated technology plan.
Nurse recruiting and retention
Tied to the staffing challenge: recruiting, scheduling and training providers support de novo staffing teams and clinical ladder programs.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Encompass Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Encompass Health

What does Encompass Health do?

It owns and operates inpatient rehabilitation hospitals that provide intensive therapy to patients recovering from strokes, hip fractures, neurological conditions and other major injuries or illnesses, mostly referred from acute-care hospitals.

What is Encompass Health's revenue?

FY2025 net operating revenues were $5,935.2 million (+10.5%). 2026 guidance is $6.45 billion to $6.50 billion.

How many employees does Encompass Health have?

Over 42,000 employees, of whom 24,611 are full-time.

Who leads Encompass Health?

Mark J. Tarr is President and CEO and Douglas E. Coltharp is Executive Vice President and CFO.

What is Encompass Health's growth strategy?

It adds capacity through de novo hospitals, bed additions and, from 2027, small-format hospitals in a hub-and-spoke model, while expanding into North Carolina and pushing Medicare Advantage and VA volume.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)